Opioid‐Associated Hippocampal Injury: Past, Present, and Future Directions
Authors:
- 22 June 2026
- journal article
- review article
- Published by Wiley in Hippocampus
- Vol. 36 (4) , e70111
Abstract
Three of the great public health challenges of our time converge at the hippocampus. The first, dementia, most commonly in the form of Alzheimer's disease, is well known to cause progressive hippocampal damage, resulting in the memory loss associated with the illness. The second, COVID‐19 infection, has thus far been linked to hippocampal alterations across multiple studies. Lastly, the third, opioids—especially in the setting of misuse—have been associated with acute and persistent hippocampal injury; this review focuses on the collection of pre‐clinical, clinical, and epidemiologic observations supporting this final relationship. Basic science work dating back decades has demonstrated a hypermetabolic response to opioids and associated damage to the hippocampus. The earliest cases recognized as opioid‐associated amnestic syndrome (OAS) were subsequently identified in 2012 and reported as part of larger case series several years later. In 2019, a related but more fulminant syndrome involving cerebellar, hippocampal, and basal nuclei transient edema with restricted diffusion (CHANTER) was first described. From these investigations, a growing body of data has since emerged to suggest that regular opioid use, particularly at higher doses or potency, may be connected to a reduction in hippocampal volume and greater risk of dementia. This review begins with a synthesis of data supporting the underlying pathological mechanisms of opioid‐associated hippocampal injury (OAHI), then covers the clinical spectrum of this phenomenon. Lastly, we will close with implications of OAHI that warrant further study, including the future epidemiologic impact on related cognitive disorders in the wake of the opioid epidemic and potential therapeutic applications of opioid antagonism for mild cognitive impairment.Keywords
Funding Information
- National Institute on Drug Abuse (1R21DA051737‐01A1)
This publication has 84 references indexed in Scilit:
- Opioid-associated syndromes and comorbidities2025
- Regular use of opioids and dementia, cognitive measures, and neuroimaging outcomes among UK Biobank participants with chronic non‐cancer painAlzheimer's & Dementia, 2025
- Prescription opioid use and cognitive function in older adults with chronic pain: A population‐based longitudinal cohort studyAlzheimer's & Dementia, 2025
- Unmasking CHANTER syndrome: A rare neurological consequence of opioid overdoseThe American Journal of Emergency Medicine, 2025
- Opioids and Dementia in the Danish PopulationJAMA Network Open, 2024
- A Rare Neurotoxicity Syndrome Following Opioid IntoxicationAnnals of Neurology, 2024
- 148th Annual Meeting American Neurological AssociationAnnals of Neurology, 2023
- Medial temporal lobe function and structure in mild cognitive impairmentAnnals of Neurology, 2004
- Demonstration of morphine in ganglion cells of the hippocampus from victims of heroin overdose by means of anti-morphine antiserum.International journal of legal medicine, 2000
- Differential effects of mu‐ and delta‐receptor selective opioid agonists on feedforward and feedback GABAergic inhibition in hippocampal brain slicesSynapse, 1991